Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.002 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |